(Q41562659)

3 October 2017

title

Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium (English)

1 reference

3 October 2017

main subject

Salmonella Typhimurium

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

4 October 2023

4

G Mathe

1 reference

3 October 2017

D. Marzin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347692

4 October 2023

C. Jasmin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347692

4 October 2023

R. Maral

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347692

4 October 2023

G. Mathe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347692

4 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6347692

4 October 2023

publication date

1 May 1983

1 reference

full work available at URL

3 October 2017

https://api.elsevier.com/content/article/PII:0277537983901803?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

https://api.elsevier.com/content/article/PII:0277537983901803?httpAccept=text/plain

4 October 2023

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

European Journal of Cancer & Clinical Oncology

4 October 2023

published in

1 reference

3 October 2017

volume

19

1 reference

3 October 2017

issue

5

1 reference

3 October 2017

page(s)

641-647

1 reference

Adriamycin. A new anticancer drug with significant clinical activity

3 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies

4 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Different incidence of breast carcinomas or fibroadenomas in daunomycin or adriamycin treated rats

4 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Tumorigenicity in vivo and induction of malignant transformation and mutagenesis in cell cultures by adriamycin and daunomycin

4 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Mutagenicity of aclacinomycin A and daunomycin derivatives

4 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test

4 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals

4 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity

4 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

Naturally occurring quinones as potential bioreductive alkylating agents

4 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(83)90180-3

4 October 2023

Identifiers

1 reference

3 October 2017

1 reference